Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-01-01
|
| Series: | Kidney Medicine |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590059522002230 |
| _version_ | 1797947093495578624 |
|---|---|
| author | Susanne B. Nicholas Radica Z. Alicic Jenny Shen |
| author_facet | Susanne B. Nicholas Radica Z. Alicic Jenny Shen |
| author_sort | Susanne B. Nicholas |
| collection | DOAJ |
| first_indexed | 2024-04-10T21:21:18Z |
| format | Article |
| id | doaj.art-f35a176d63614ed1b4a89c7e91ca8adf |
| institution | Directory Open Access Journal |
| issn | 2590-0595 |
| language | English |
| last_indexed | 2024-04-10T21:21:18Z |
| publishDate | 2023-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Kidney Medicine |
| spelling | doaj.art-f35a176d63614ed1b4a89c7e91ca8adf2023-01-20T04:26:02ZengElsevierKidney Medicine2590-05952023-01-0151100590Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United StatesSusanne B. Nicholas0Radica Z. Alicic1Jenny Shen2Department of Medicine, Division of Nephrology, David Geffen School of Medicine, University of California, Los Angeles, California; Address for Correspondence: Susanne B. Nicholas, MD, MPH, PhD, Department of Medicine, Division of Nephrology, 7-155 Factor Bldg, 10833 LeConte Blvd, Los Angeles, CA 90095.Providence Medical Research Center, Providence Inland Northwest, Spokane, Washington; Department of Medicine, University of Washington, Seattle, WashingtonLundquist Institute at Harbor-UCLA Medical Center, Torrance, Californiahttp://www.sciencedirect.com/science/article/pii/S2590059522002230 |
| spellingShingle | Susanne B. Nicholas Radica Z. Alicic Jenny Shen Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States Kidney Medicine |
| title | Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States |
| title_full | Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States |
| title_fullStr | Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States |
| title_full_unstemmed | Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States |
| title_short | Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States |
| title_sort | disparities in the use of sglt2 inhibitors and glucagon like peptide 1 receptor agonists in adults with ckd in the united states |
| url | http://www.sciencedirect.com/science/article/pii/S2590059522002230 |
| work_keys_str_mv | AT susannebnicholas disparitiesintheuseofsglt2inhibitorsandglucagonlikepeptide1receptoragonistsinadultswithckdintheunitedstates AT radicazalicic disparitiesintheuseofsglt2inhibitorsandglucagonlikepeptide1receptoragonistsinadultswithckdintheunitedstates AT jennyshen disparitiesintheuseofsglt2inhibitorsandglucagonlikepeptide1receptoragonistsinadultswithckdintheunitedstates |